← All trials
NCT02176369
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2013
- Primary completion
- Jun 1, 2018
- Completion date
- Oct 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 120
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of MilanLead sponsor
- AUSL Piacenza - Ospedale Guglielmo da SalicetoOverall official - principal investigator
- A.O. Ospedale di Circolo di Busto ArsizioOverall official - principal investigator
- AUSL Viterbo - Ospedale di BelcolleOverall official - principal investigator
- Casa di Cura Dott. Pederzoli - Peschiera del GardaOverall official - principal investigator
- A.O. Santa Maria Degli Angeli - PordenoneOverall official - principal investigator
- A.O. Valtellina e ValchiavennaOverall official - principal investigator
- A.O. Villa ScassiOverall official - principal investigator
- ASL BrindisiOverall official - principal investigator
- Ospedale E. ProfiliOverall official - principal investigator
- Ospedale S.M. della MisericordiaOverall official - principal investigator
- Ospedale Morelli, SondaloOverall official - principal investigator
- Azienda Sanitaria dell'Alto AdigeOverall official - principal investigator
- University of TurinOverall official - principal investigator
- University of CataniaOverall official - principal investigator
- University of PalermoOverall official - principal investigator
- Ospedale di CircoloOverall official - principal investigator
- A.O. Ospedale di Circolo di MelegnanoOverall official - principal investigator
- Regione LombardiaCollaborator
- Azienda USL 4 PratoOverall official - principal investigator
- Ospedale San Vincenzo TaorminaOverall official - principal investigator
- University of MilanOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.